Robert A. Soslow

Active 1996–2025

209
Papers
31,420
Citations
109
h-index
207
i10-index

Citations

Citations per year for Robert A. Soslow1993: 1 citations1996: 1 citations1997: 1 citations1999: 9 citations2000: 60 citations2001: 75 citations2002: 95 citations2003: 95 citations2004: 112 citations2005: 92 citations2006: 78 citations2007: 94 citations2008: 84 citations2009: 114 citations2010: 140 citations2011: 146 citations2012: 172 citations2013: 180 citations2014: 200 citations2015: 289 citations2016: 278 citations2017: 327 citations2018: 325 citations2019: 1,019 citations2020: 1,243 citations2021: 1,186 citations2022: 936 citations2023: 599 citations2024: 1,060 citations2025: 358 citations2026: 7 citations1994–1995: no citations, so these years are not shown1998: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,689 citing papers, 28.7% of this breakdownChina: 823 citing papers, 8.8% of this breakdownCanada: 621 citing papers, 6.6% of this breakdownItaly: 581 citing papers, 6.2% of this breakdownUnited Kingdom: 573 citing papers, 6.1% of this breakdownGermany: 379 citing papers, 4% of this breakdownJapan: 357 citing papers, 3.8% of this breakdownFrance: 320 citing papers, 3.4% of this breakdownSpain: 283 citing papers, 3% of this breakdownNetherlands: 267 citing papers, 2.8% of this breakdownAustralia: 243 citing papers, 2.6% of this breakdownSwitzerland: 140 citing papers, 1.5% of this breakdown
0%28.7%Other 22.5%

Fields

  • Medicine75.6%
  • Biochemistry, Genetics and Molecular Biology19.6%
  • Immunology and Microbiology2%
  • Computer Science0.8%
  • Dentistry0.3%
  • Chemistry0.3%
  • Other1.4%

Topics

  • Endometrial and Cervical Cancer Treatments10.9%
  • Ovarian cancer diagnosis and treatment9%
  • Uterine Myomas and Treatments3.1%
  • Genetic factors in colorectal cancer2.6%
  • Cancer Genomics and Diagnostics2.5%
  • Sarcoma Diagnosis and Treatment2.4%
  • Other69.5%

Coauthors

All papers

Open in search
  1. Ovarian cancer mutational processes drive site-specific immune evasion

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yukio Sonoda, Oliver Zivanovic, Ritika Kundra, Agnès Viale, Fatemeh Derakhshan, Luke Geneslaw, Shirin Issa Bhaloo, Ana Maroldi, Rahelly Nunez, Fresia Pareja, Anthe A. Stylianou, Mahsa Vahdatinia, Yonina Bykov, Rachel N. Grisham, Ying L. Liu, Yulia Lakhman, Ines Nikolovski, Daniel J. Kelly, Jianjiong Gao, Andrea Schietinger, Travis J. Hollmann, Samuel F. Bakhoum, Robert A. Soslow, Lora H. Ellenson, Nadeem R. Abu‐Rustum, Carol Aghajanian, Claire F. Friedman, Andrew McPherson, Britta Weigelt, Dmitriy Zamarin, Sohrab P. Shah - Nature 2022 cited by 307

  2. Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas

    Authors: , , , , , , , , , , , , , , , , , , - The Journal of Pathology 2019 cited by 402

  3. Type I and II Endometrial Cancers: Have They Different Risk Factors?

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kirsten B. Moysich, Anthony B. Miller, Marjorie L. McCullough, Rayna K. Matsuno, Anthony M. Magliocco, Galina Lurie, Lingeng Lu, Jolanta Lissowska, Xiaolin Liang, James V. Lacey, Laurence N. Kolonel, Brian E. Henderson, Susan E. Hankinson, Niclas Håkansson, Marc T. Goodman, Mia M. Gaudet, Montserrat García‐Closas, Christine M. Friedenreich, Jo L. Freudenheim, Jennifer A. Doherty, Immaculata De Vivo, Kerry S. Courneya, Linda S. Cook, Chu Chen, James R. Cerhan, Hui Cai, Louise A. Brinton, Leslie Bernstein, Kristin E. Anderson, Hoda Anton‐Culver, Leo J. Schouten, Pamela L. Horn‐Ross - Journal of Clinical Oncology 2013 cited by 833

  4. Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

    Authors: , , , , , , , , , , , , , , , , - The American Journal of Surgical Pathology 2018 cited by 342

  5. Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility

    Authors: , , , , , - International Journal of Gynecological Pathology 2018 cited by 398

  6. Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexandra Snyder, Britta Weigelt, Evis Sala, Martin L. Miller - Nature Genetics 2020 cited by 253

  7. Classification of endometrial carcinoma: more than two types

    Authors: , , - The Lancet Oncology 2014 cited by 663

  8. OncoTree: A Cancer Classification System for Precision Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah P. Suehnholz, Moriah H. Nissan, Gopa Iyer, Rajmohan Murali, Nancy Bouvier, Robert A. Soslow, David M. Hyman, Anas Younes, Andrew M. Intlekofer, James J. Harding, Richard D. Carvajal, Paul Sabbatini, Ghassan K. Abou‐Alfa, Luc G.T. Morris, Yelena Y. Janjigian, Meighan M. Gallagher, Tara A. Soumerai, Ingo K. Mellinghoff, A. Ari Hakimi, Matthew G. Fury, Jason T. Huse, Aditya Bagrodia, Meera Hameed, Stacy B. Thomas, Stuart M. Gardos, Ethan Cerami, Tali Mazor, Priti Kumari, Pichai Raman, Priyanka Shivdasani, Suzanne P. MacFarland, Scott Newman, Angela J. Waanders, Jianjiong Gao, David B. Solit, Nikolaus Schultz - JCO Clinical Cancer Informatics 2021 cited by 150

  9. Integrated Molecular Characterization of Uterine Carcinosarcoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rebecca Carlsen, Andrew D. Cherniack, Juok Cho, Eric Chuah, Sudha Chudamani, Kristian Cibulskis, Melissa Cline, Fanny Dao, Mutch David, John A. Demchok, Noreen Dhalla, Sean C. Dowdy, Ina Felau, Martin L. Ferguson, Scott Frazer, Jessica Frick, Stacey Gabriel, Julie M. Gastier‐Foster, Nils Gehlenborg, Mark Gerken, Gad Getz, Manaswi Gupta, David Haussler, D. Neil Hayes, David I. Heiman, Julian M. Hess, Katherine A. Hoadley, Robert Hoffmann, Robert A. Holt, Alan P. Hoyle, Xin Hu, Mei Huang, Carolyn M. Hutter, Stuart R. Jefferys, Steven J.M. Jones, Corbin D. Jones, Rupa S. Kanchi, Cyriac Kandoth, Katayoon Kasaian, Sarah E. Kerr, Jaegil Kim, Phillip H. Lai, Peter W. Laird, Eric S. Lander, Michael S. Lawrence, Darlene Lee, Kristen Leraas, Ignaty Leshchiner, Douglas A. Levine, Tara M. Lichtenberg, Pei Lin, Shiyun Ling, Jia Liu, Wenbin Liu, Yuexin Liu, Laxmi Lolla, Yiling Lu, Yussanne Ma, Dennis T. Maglinte, Marco A. Marra, Michael Mayo, Shaowu Meng, Matthew Meyerson, Piotr A. Mieczkowski, Gordon B. Mills, Richard A. Moore, Lisle E. Mose, Andrew J. Mungall, Karen Mungall, Bradley A. Murray and 65 more - Cancer Cell 2017 cited by 444

  10. International Endocervical Adenocarcinoma Criteria and Classification (IECC)

    Authors: , , , , , , , , , , , , - The American Journal of Surgical Pathology 2017 cited by 400

  11. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists

    Authors: , , , , , , , , , - International Journal of Gynecological Pathology 2018 cited by 317

  12. Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma

    Authors: , , - The American Journal of Surgical Pathology 2013 cited by 412

  13. Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Soslow, Anna DeFazio, Michael J. Birrer, Joe W. Gray, John N. Weinstein, David D.L. Bowtell, Ronny Drapkin, Jill P. Mesirov, Gad Getz, Douglas A. Levine, Matthew Meyerson - Journal of Clinical Investigation 2012 cited by 591

  14. TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 77

  15. Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas

    Authors: , , , , , , , , , , , , - Modern Pathology 2010 cited by 254

  16. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary

    Authors: , , , , , , , , , , , - Nature Genetics 2014 cited by 377

  17. Genomic landscape of endometrial carcinomas of no specific molecular profile

    Authors: , , , , , , , , - Modern Pathology 2022 cited by 87

  18. Clinicopathologic and Genomic Analysis of TP53 -Mutated Endometrial Carcinomas

    Authors: , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 106

  19. Gastric-type Endocervical Adenocarcinoma

    Authors: , , , , , , , - The American Journal of Surgical Pathology 2015 cited by 316

  20. The genetic landscape of endometrial clear cell carcinomas

    Authors: , , , , , , , , , , - The Journal of Pathology 2017 cited by 228

  21. Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , - Scientific Reports 2020 cited by 70

  22. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations

    Authors: , , , , , , , , , , , , , , , , , - International Journal of Gynecological Pathology 2018 cited by 282

  23. Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC)

    Authors: , , , , , , , , , , , , - The American Journal of Surgical Pathology 2019 cited by 152

  24. Pathologic Ultrastaging Improves Micrometastasis Detection in Sentinel Lymph Nodes During Endometrial Cancer Staging

    Authors: , , , , , , , , , - International Journal of Gynecological Cancer 2013 cited by 276